Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Colorectal Neoplasms

  Free Subscription


3 Ann Surg Oncol
1 Anticancer Res
2 BMC Cancer
1 Cancer Lett
1 Clin Med Insights Oncol
1 Dis Colon Rectum
1 Eur J Cancer
2 Gastroenterology
1 Gastrointest Endosc
1 Gut
2 Int J Colorectal Dis
1 Lancet Oncol
1 PLoS Comput Biol
1 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Surg Oncol

  1. VERBUS EA, Rossi AJ, Luna AJ, Iqbal A, et al
    Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy for Patients with Stage 2A Colon Cancer (COBRA).
    Ann Surg Oncol. 2021 May 17. pii: 10.1245/s10434-021-10112.

  2. NAKANISHI R, Oki E, Hasuda H, Sano E, et al
    Radiomics Texture Analysis for the Identification of Colorectal Liver Metastases Sensitive to First-Line Oxaliplatin-Based Chemotherapy.
    Ann Surg Oncol. 2021;28:2975-2985.
    PubMed         Abstract available

  3. QWAIDER YZ, Sell NM, Stafford CE, Kunitake H, et al
    Infiltrating Tumor Border Configuration is a Poor Prognostic Factor in Stage II and III Colon Adenocarcinoma.
    Ann Surg Oncol. 2021;28:3408-3414.
    PubMed         Abstract available

    Anticancer Res

  4. NORZ D, Mullins CS, Smit DJ, Linnebacher M, et al
    Combined Targeting of AKT and mTOR Synergistically Inhibits Formation of Primary Colorectal Carcinoma Tumouroids In Vitro: A 3D Tumour Model for Pre-therapeutic Drug Screening.
    Anticancer Res. 2021;41:2257-2275.
    PubMed         Abstract available

    BMC Cancer

  5. SUSMI TF, Rahman A, Khan MMR, Yasmin F, et al
    Prognostic and clinicopathological insights of phosphodiesterase 9A gene as novel biomarker in human colorectal cancer.
    BMC Cancer. 2021;21:577.
    PubMed         Abstract available

  6. ADENIS A, Mazard T, Fraisse J, Chalbos P, et al
    FOLFIRINOX-R study design: a phase I/II trial of FOLFIRINOX plus regorafenib as first line therapy in patients with unresectable RAS-mutated metastatic colorectal cancer.
    BMC Cancer. 2021;21:564.
    PubMed         Abstract available

    Cancer Lett

  7. CHEN J, Wang H, Jia L, He J, et al
    Bufalin targets the SRC-3/MIF pathway in chemoresistant cells to regulate M2 macrophage polarization in colorectal cancer.
    Cancer Lett. 2021 May 14. pii: S0304-3835(21)00223.
    PubMed         Abstract available

    Clin Med Insights Oncol

  8. HAN Z, Zhang C, Wang Q, Li L, et al
    MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway.
    Clin Med Insights Oncol. 2021;15:11795549211012666.
    PubMed         Abstract available

    Dis Colon Rectum

  9. SUWA Y, Watanabe J, Ozawa M, Ishibe A, et al
    A Direct Approach to the Superior Mesenteric Artery for Dissection of the Proximal Lymph Nodes in Splenic Flexure Colon Cancer Patients with an Accessory Middle Colic Artery.
    Dis Colon Rectum. 2021 May 11. pii: 00003453-900000000-99463.

    Eur J Cancer

  10. SATTLER EC, Syunyaeva Z, Reithmair M, Dempke W, et al
    Colorectal cancer risk in families with Birt-Hogg-Dube syndrome increased.
    Eur J Cancer. 2021;151:168-174.
    PubMed         Abstract available


  11. RATOVOMANANA T, Cohen R, Svrcek M, Renaud F, et al
    Performance of Next Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer with Deficient DNA Mismatch Repair.
    Gastroenterology. 2021 May 13. pii: S0016-5085(21)02977.
    PubMed         Abstract available

  12. ECKER J, Benedetti E, Kindt ASD, Horing M, et al
    The colorectal cancer lipidome - identification of a robust tumor-specific lipid species signature.
    Gastroenterology. 2021 May 14. pii: S0016-5085(21)02979.
    PubMed         Abstract available

    Gastrointest Endosc

  13. YANG D, Draganov PV
    Endoscopic resection of T1 colorectal cancer before surgery does not affect recurrence.
    Gastrointest Endosc. 2021 May 11. pii: S0016-5107(21)00259.


  14. MURPHY N, Campbell PT, Gunter MJ
    Are sugar-sweetened beverages contributing to the rising occurrence of colorectal cancer in young adults?
    Gut. 2021 May 20. pii: gutjnl-2021-324614. doi: 10.1136/gutjnl-2021-324614.

    Int J Colorectal Dis

  15. MILLER-WILSON LA, Rutten LJF, Van Thomme J, Ozbay AB, et al
    Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a large, nationally insured cohort.
    Int J Colorectal Dis. 2021 May 21. pii: 10.1007/s00384-021-03956.
    PubMed         Abstract available

  16. ABDEL-RAHMAN O, Tang PA, Koski S
    Hospitalizations among early-stage colon cancer patients receiving adjuvant chemotherapy: a real-world study.
    Int J Colorectal Dis. 2021 May 21. pii: 10.1007/s00384-021-03952.
    PubMed         Abstract available

    Lancet Oncol

  17. CONROY T, Bosset JF, Etienne PL, Rio E, et al
    Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.
    Lancet Oncol. 2021;22:702-715.
    PubMed         Abstract available

    PLoS Comput Biol

  18. BEAL J, Pantolini L, Noel V, Barillot E, et al
    Personalized logical models to investigate cancer response to BRAF treatments in melanomas and colorectal cancers.
    PLoS Comput Biol. 2021;17:e1007900.
    PubMed         Abstract available

    PLoS One

  19. HELMER RA, Martinez-Zaguilan R, Kaur G, Smith LA, et al
    Helicase-like transcription factor-deletion from the tumor microenvironment in a cell line-derived xenograft model of colorectal cancer reprogrammed the human transcriptome-S-nitroso-proteome to promote inflammation and redirect metastasis.
    PLoS One. 2021;16:e0251132.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  20. CAGNONI AJ, Giribaldi ML, Blidner AG, Cutine AM, et al
    Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8(+) regulatory T cells.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.